2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO25] Mini-Oral Session 25　Translational Research / Clinical Pharmacology 4（Miscellaneous）
【E】

Fri. Feb 18, 2022 2:05 PM - 2:45 PM Room 8 (Sakura, 1F, Kyoto International Conference Center)

Chair：Chiyo K. Imamura（Advanced Cancer Translational Research Institute, Showa University），Yoshitsugu Horio（Department of Outpatient Services, Aichi Cancer Center Hospital）

[MO25-3] Regorafenib-induced erythema multiforme is associated with HLA-C*01:02 and HLA-B*46:01 in Japanese cancer patients

○Natsumi Matsumoto1, Kosuke Takeshima1, Yutaro Kubota2, Hiroo Ishida2, Takuya Taunoda2, Yasutsuna Sasaki2, Ken-Ichi Fujita1 (1.Division of Cancer Genome and Pharmacotherapy, Showa University School of Pharmacy, 2.Division of Medical Oncology, Showa University School of Medicine)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password